Specifically, the levels of NFATc2 and RUNX2 were markedly elevated in PD (GSE7621) and Braak stages 5/6 (GSE49036) relative to the control subjects, but not in GSE26927. This evidence concerns the gene NFATC2 and Parkinson disease.